Advertisement

Topics

Receptor Biology Incorporated Company Profile

06:17 EDT 22nd October 2017 | BioPortfolio

Receptor Biology Inc. produce cloned receptors for pharmacology studies and drug discovery, products include adenosine, cannabinoid, dopamine, muscarinic, serotonin, opoid, bradykinin, transporter, wild type.

Location

10,000 Virginia Manor Road, Suite 360
Beltsville
MD
20705
United States of America

Contact

Phone: 301 210 4700


News Articles [856 Associated News Articles listed on BioPortfolio]

A sugar high in structural biology

Four Nature papers describing the receptor structures involved in glucose metabolism hold great promise for finding new ways to treat diabetes.

How Blood Vessels Control Their Destiny

NewsResearchers define the importance of the decoy receptor VEGFR1 in the process of angiogenesis, in findings that could have important implications in the treatment of cancer and other diseases.

Hormone Receptor Antibody Reagents Assessed for Breast Cancer

Immunohistochemical analysis of estrogen receptor (ER) and progesterone receptor (PgR) expression in breast cancer is the current standard of care...

The Great Untangling

Here’s a family of proteins that people don’t encounter all that often, but they illustrate how odd and complicated human biology gets to be. The TRP (transient receptor potential) ion c...

New book on The Biology of the TGF-β Family from Cold Spring Harbor Laboratory Press

(Cold Spring Harbor Laboratory Press) "The Biology of the TGF-β Family" provides a comprehensive view of the different members of the TGF-β family, the signaling pathways they control, and h...

First image of major brain receptor caught in action

Researchers have captured the first three-dimensional snapshots of the AMPA-subtype glutamate receptor in action. The receptor, which regulates most electrical signaling in the brain, is involved in s...

Somatic loss of estrogen receptor beta and p53 synergize to induce breast tumorigenesis

Upregulation of estrogen receptor beta (ERβ) in breast cancer cells is associated with epithelial maintenance, decreased proliferation and invasion, and a reduction in the expression of the receptor ...

Amgen Foundation Awards Khan Academy $3 Million To Support Development Of Free Comprehensive Biology Lessons

More Than One Million Students Access Biology Content Each Month THOUSAND OAKS, Calif. and MOUNTAIN VIEW, Calif., Oct. 12, 2017 /PRNewswire/ -- The Amgen Foundation today announced a three-year, $3 ...

PubMed Articles [2385 Associated PubMed Articles listed on BioPortfolio]

The vitamin D receptor: contemporary genomic approaches reveal new basic and translational insights.

The vitamin D receptor (VDR) is the single known regulatory mediator of hormonal 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] in higher vertebrates. It acts in the nucleus of vitamin D target cells to regul...

VDR gene methylation as a molecular adaption to light exposure: Historic, recent and genetic influences.

The vitamin D receptor (VDR) is a member of the nuclear receptor family of transcription factors. We examined whether degree of VDR gene methylation acts as a molecular adaptation to light exposure. W...

Dynamic complexity: plant receptor complexes at the plasma membrane.

Plant receptor complexes at the cell surface perceive many different external and internal signalling molecules and relay these signals into the cell to regulate development, growth and immunity. Rece...

Structural biology: A receptor that might block itself.

All biology is computational biology.

Here, I argue that computational thinking and techniques are so central to the quest of understanding life that today all biology is computational biology. Computational biology brings order into our ...

Clinical Trials [1796 Associated Clinical Trials listed on BioPortfolio]

Evaluate the Safety and Efficacy of CAR-T in the Treatment of Pancreatic Cancer.

Immunotherapy has become the major breakthrough and the most promising treatment, with the host of development of tumor biology, molecular biology and immunology. It has become the fourth ...

Evaluation of Chemotherapy Influence on Clinical and Biological Markers of Ovarian Reserve

The objective is to evaluate the influence of chemotherapy, either for auto-immune disease, either for carcinologic disease, on clinical and biological markers of ovarian reserve, for youn...

18F-Florbetaben PET Amyloid Imaging in Case of Intermediate CSF Biology for the Diagnosis of Alzheimer's Disease : a Pilot Study

The diagnosis of Alzheimer's disease (AD) is based on clinical and neuropathological criteria. Some patients have a contributive CSF biology to determinate a high level risk of AD (Tau +...

Ex-vivo Sentinel Lymph Node in Stage I-II Colon Cancer: Kappa Analysis With Immunochemistry and Molecular Biology

Unmask Trial aims to evaluate the Kappa concordance between immunochemistry and molecular biology to detecting cancer cells in sentinel lymph node in patients undergoing colectomy for non ...

Systems Biology Approach to Cognitive Impairment After SepsiS

This study will use systems biology techniques, especially RNA-seq, to understand cognitive impairment after sepsis requiring an intensive care unit (ICU) admission.

Companies [806 Associated Companies listed on BioPortfolio]

Receptor Biology Incorporated

Receptor Biology Inc. produce cloned receptors for pharmacology studies and drug discovery, products include adenosine, cannabinoid, dopamine, muscarinic, serotonin, opoid, bradykinin, transporter, wi...

Angstrom Pharmaceuticals Incorporated

Ångstrom Pharmaceuticals, Inc. was formed in 1996 to add a new dimension to drug discovery. It is committed to discovering drugs that block the docking of an extracellular regulatory protein (ligand)...

Aragon Pharmaceuticals Inc.

Aragon Pharmaceuticals is a privately held small-molecule drug discovery company identifying breakthrough medicines for the treatment of hormonally driven cancers. These cancers are traditionally trea...

Receptor BioLogix, Inc.

Receptor BioLogix, Inc. is a biopharmaceutical company focused on developing the first broad-spectrum anti-HER therapeutic, resulting from its program to commercialize a newly discovered class of prot...

Receptor BioLogix

Receptor BioLogix, Inc. is a biopharmaceutical company focused on developing the first broad-spectrum anti-HER therapeutic, resulting from its program to commercialize a newly discovered class of prot...

More Information about "Receptor Biology Incorporated" on BioPortfolio

We have published hundreds of Receptor Biology Incorporated news stories on BioPortfolio along with dozens of Receptor Biology Incorporated Clinical Trials and PubMed Articles about Receptor Biology Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Receptor Biology Incorporated Companies in our database. You can also find out about relevant Receptor Biology Incorporated Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record